Cohen, S., Genovese, M. C., Choy, E., Perez-Ruiz, F., Matsumoto, A., Pavelka, K., . . . Kaur, P. (2017). Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: A randomised, double-blind, phase III equivalence study. Ann Rheum Dis.
Styl cytowania ChicagoCohen, Stanley, et al. "Efficacy and Safety of the Biosimilar ABP 501 Compared With Adalimumab in Patients With Moderate to Severe Rheumatoid Arthritis: A Randomised, Double-blind, Phase III Equivalence Study." Ann Rheum Dis 2017.
Styl cytowania MLACohen, Stanley, et al. "Efficacy and Safety of the Biosimilar ABP 501 Compared With Adalimumab in Patients With Moderate to Severe Rheumatoid Arthritis: A Randomised, Double-blind, Phase III Equivalence Study." Ann Rheum Dis 2017.